Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study

Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study

Bibliographic Details
Main Authors:	Luciano Ibba, Luigi Gargiulo, Angela Alfano, Ruggero Cascio Ingurgio, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Journal of Dermatological Treatment
Subjects:	biologics palmoplantar psoriasis real-life
Online Access:	http://dx.doi.org/10.1080/09546634.2023.2199108

Similar Items

Risankizumab for the Treatment of Palmoplantar Pustular Psoriasis: A Report of Two Cases
by: Luigi Gargiulo, et al.
Published: (2023-04-01)

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
by: Madison Hackley, et al.
Published: (2023-10-01)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
by: Sascha Ständer, et al.
Published: (2020-10-01)

Anti-IL17 and anti-IL23 biologic drugs for genital psoriasis: a single-center retrospective comparative study
by: Andrea Cortese, et al.
Published: (2023-05-01)

Dermoscopy in the diagnosis of palmoplantar eczema and palmoplantar psoriasis: A cross-sectional, comparative study from a tertiary care centre in North India
by: Payal Chauhan, et al.
Published: (2023-01-01)

Natalizumab-Induced Pustular Psoriasis of Palms and Soles
by: Bengisu Ozarslan, et al.
Published: (2022-05-01)

Pustular Psoriasis: From Pathophysiology to Treatment
by: Giovanni Genovese, et al.
Published: (2021-11-01)

Black Cumin Oil: A New Treatment for Palmoplantar Psoriasis.
by: Naseer A. Al-Harchan
Published: (2010-07-01)

Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: An observer-blinded randomized controlled study
by: Bijal H Mehta, et al.
Published: (2011-01-01)

Improvement of Anti-TNF-α Antibody-Induced Palmoplantar Pustular Psoriasis Using a 308-nm Excimer Light
by: Natsuko Iga, et al.
Published: (2012-11-01)

Successful treatment of palmoplantar psoriasis with chemical peeling and gentian violet
by: Jeffrey A. Bubley, MD, et al.
Published: (2021-11-01)

Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
by: Al Muqrin AM, et al.
Published: (2022-10-01)

Secukinumab-induced paradoxical palmoplantar pustular psoriasis
by: Yıldız Gürsel Ürün, et al.
Published: (2022-12-01)

Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients,
by: Yu Xiaoling, et al.
Published: (2020-02-01)

Efficacy and safety of acitretin monotherapy in children with pustular psoriasis: results from 15 cases and a literature review
by: Pingjiao Chen, et al.
Published: (2018-05-01)

Monochromatic excimer light in south indian patients (Skin type IV, V, and VI) with palmoplantar psoriasis: A case series
by: Saritha Mohanan, et al.
Published: (2023-01-01)

A prospective study of clinical profile in patients of palmoplantar dermatoses
by: Pragya A Nair, et al.
Published: (2017-01-01)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
by: A. David Burden, et al.
Published: (2023-09-01)

Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study
by: Paolo Gisondi, et al.
Published: (2022-07-01)

Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers
by: Diego Orsini, et al.
Published: (2023-12-01)

Skin microbiota in patients with psoriasis vulgaris and pustular psoriasis
by: E. A. Bakhlykova, et al.
Published: (2017-08-01)

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)
by: Luigi Gargiulo, et al.
Published: (2024-01-01)

Palmoplantar Psoriasis: A Clinico-Pathologic Study on a Series of 21 Cases with Emphasis on Differential Diagnosis
by: Giuseppe Broggi, et al.
Published: (2022-12-01)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
by: Chu Y, et al.
Published: (2022-09-01)

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
by: Heidemeyer K, et al.
Published: (2023-09-01)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
by: Xu Q, et al.
Published: (2023-08-01)

Polymorphisms of PDCD1 and COL9A1 Genes in Plaque, Palmoplantar and Arthropathic Psoriasis in Romanian Patients
by: Doriana-Sorina Lupea-Chilom, et al.
Published: (2024-03-01)

Effects of Cyclosporine on Palmoplantar Pustulosis and Serum Expression of IL-17, IL-23, and TNF-α
by: Xian-Hua Jin, et al.
Published: (2019-06-01)

Punctate Palmoplantar Keratoderma
by: Susana Cláudia Teixeira, et al.
Published: (2021-09-01)

Punctate Palmoplantar Keratoderma
by: Susana Cláudia Teixeira, et al.
Published: (2021-09-01)

Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study
by: Giovanni Fiorillo, et al.
Published: (2024-02-01)

Combination biologic therapy for the treatment of severe palmoplantar pustulosis
by: Kristin M. Torre, BS, et al.
Published: (2017-05-01)

Topical Psoralen and Sunlight in Treatment of Palmoplantar Psoriasis in Iraqi Patients
by: Mohammed Ahmed Mahdi
Published: (2019-11-01)

Topical Psoralen and Sunlight in Treatment of Palmoplantar Psoriasis in Iraqi Patients
by: Mohammed Ahmed Mahdi
Published: (2019-11-01)

Comparative therapeutic evaluation of different topicals and narrow band ultraviolet B therapy combined with systemic methotrexate in the treatment of palmoplantar psoriasis
by: Sunil K Gupta, et al.
Published: (2011-01-01)

Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study
by: Luciano Ibba, et al.
Published: (2023-12-01)

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks
by: Luciano Ibba, et al.
Published: (2023-06-01)

Psoriasis in special localizations
by: Klaudia Dopytalska, et al.
Published: (2018-12-01)

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
by: Haugh IM, et al.
Published: (2018-11-01)

Unna Thost Keratoderma palmoplantar . A Case Report
by: Graciela Caridad Cabrera Acea, et al.
Published: (2011-08-01)